Projects for classification, surveillance and therapy in pediatric rheumatology

Projects for classification, surveillance and therapy in pediatric rheumatology - Pro-Kind Rheuma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032928

Enrollment

700

Registered

2026-04-14

Start date

2020-07-31

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M08.4 M08.0 M08.2

Interventions

Group 1: - T2T (Treat to Target) treatment = intervention (identification of patients in cohort) Group 2: Comparison to historic cohort ICON) and health insurance cohort (Barmer)

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Patients with newly onset JIA, SLE. JDM and autoinflammatory diseases

Exclusion criteria

Exclusion criteria: onset more than 6 months in patioents with JIA

Design outcomes

Primary

Measure	Time frame
Recording of outcomes: treatment-free remission, quality of life, dates, medical costs	—

Secondary

Measure	Time frame
Determination of predictors of successful discontinuation of therapy	—

Countries

Germany

Contacts

Public ContactKlaus Tenbrock

Uniklinik RWTH Aachen

ktenbrock@ukaachen.de+492418035486

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026